Italian guidelines for diagnosis, prevention, and treatment of invasive fungal infections in solid organ transplant recipients (Q37916824)

25 August 2017

Italian guidelines for diagnosis, prevention, and treatment of invasive fungal infections in solid organ transplant recipients (English)

1 reference

invasive fungal infections

25 August 2017

0 references

1 reference

F Pea

10

0 references

author name string

P A Grossi

1

1 reference

25 August 2017

D Dalla Gasperina

2

1 reference

25 August 2017

F Barchiesi

3

1 reference

25 August 2017

G Biancofiore

4

1 reference

25 August 2017

G Carafiello

5

1 reference

25 August 2017

A De Gasperi

6

1 reference

25 August 2017

G Sganga

7

1 reference

25 August 2017

F Menichetti

8

1 reference

25 August 2017

M T Montagna

9

1 reference

25 August 2017

M Venditti

11

1 reference

25 August 2017

P Viale

12

1 reference

25 August 2017

C Viscoli

13

1 reference

25 August 2017

A Nanni Costa

14

1 reference

25 August 2017

language of work or name

English

0 references

publication date

1 July 2011

1 reference

Transplantation Proceedings

25 August 2017

1 reference

25 August 2017

43

1 reference

25 August 2017

2463-2471

1 reference

25 August 2017

6

1 reference

Infection in solid-organ transplant recipients

25 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Introduction: infection in solid organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Fungal infections in solid organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Candida in solid organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Invasive aspergillosis in solid organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Emerging & rare fungal infections in solid organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Fungal infections in lung transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Aspergillus Galactomannan Antigen in the Bronchoalveolar Lavage Fluid for the Diagnosis of Invasive Aspergillosis in Lung Transplant Recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Reappraisal of the serum (1-->3)-beta-D-glucan assay for the diagnosis of invasive fungal infections--a study based on autopsy cases from 6 years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Serologic evidence for reactivation of cryptococcosis in solid-organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Cryptococcosis in solid organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Real-time PCR in clinical microbiology: applications for routine laboratory testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Donor-derived infections in solid organ transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Invasive aspergillosis in transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Imaging features of invasive and noninvasive fungal sinusitis: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Fungal liver infection in immunocompromised patients: depiction with multiphasic contrast-enhanced helical CT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Detection of acute and treated lesions of hepatosplenic candidiasis: comparison of dynamic contrast-enhanced CT and MR imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Hepatosplenic fungal disease: diagnostic accuracy and spectrum of appearances on MR imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Clinical aspects of invasive candidiasis in solid organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Antifungal prophylaxis in liver transplant patients: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Antifungal agents for preventing fungal infections in non-neutropenic critically-ill patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Safety of aerosolized amphotericin B lipid complex in lung transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Comparison of caspofungin and amphotericin B for invasive candidiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Anidulafungin versus fluconazole for invasive candidiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Echinocandins--an advance in the primary treatment of invasive candidiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Plasma levels of voriconazole administered via a nasogastric tube to critically ill patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

A case of Aspergillus mediastinitis after heart transplantation successfully treated with liposomal amphotericin B, caspofungin and voriconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Aspergillus fumigatus empyema, arthritis, and calcaneal osteomyelitis in a lung transplant patient successfully treated with posaconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Native lung pneumonectomy for invasive pulmonary aspergillosis following lung transplantation: a case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Rhino-orbital-cerebral zygomycosis in solid organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Antifungal therapy in invasive fungal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Posaconazole as salvage therapy for zygomycosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Posaconazole mono- or combination therapy for treatment of murine zygomycosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Fusarium infections in immunocompromised patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.06.020

10.1016/J.TRANSPROCEED.2011.06.020

7 January 2021

Identifiers

DOI

1 reference

25 August 2017

1 reference